title: Risk of thromboembolism with lymphoma: myth or reality?
authors.affiliation: a Division of Cancer Medicine , Peter MacCallum Cancer Centre , East Melbourne , Melbourne , Australia.
authors.forename: Kate L
authors.initials: KL
authors.lastname: Burbury
authors.affiliation: a Division of Cancer Medicine , Peter MacCallum Cancer Centre , East Melbourne , Melbourne , Australia.|b Monash University , Clayton , Victoria , Australia.
authors.forename: Marliese
authors.initials: M
authors.lastname: Alexander
authors.affiliation: a Division of Cancer Medicine , Peter MacCallum Cancer Centre , East Melbourne , Melbourne , Australia.|c University of Melbourne , Parkville , Victoria , Australia.
authors.forename: David A
authors.initials: DA
authors.lastname: Westerman
mesh_terms: D018890:Chemoprevention / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008223:Lymphoma / Q000150:complications* / Q000453:epidemiology; D015201:Meta-Analysis as Topic; D018570:Risk Assessment; D012307:Risk Factors; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents